# Merz Pharmaceuticals GmbH clinical trials: 61 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 61 trials with Merz Pharmaceuticals GmbH as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Merz Pharmaceuticals GmbH: 61 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/merz-pharmaceuticals-gmbh

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 61
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 61, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 18, 2022 | NCT05585398 | A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Different Doses... | Merz Pharmaceuticals GmbH | Phase 1 | Completed | N/A, as no Specific Medical Condition Will be Treated | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05585398) |
| February 23, 2021 | NCT04766723 | A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants... | Merz Pharmaceuticals GmbH | Phase 2 | Completed | Essential Tremor of the Upper Limb | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04766723) |
| December 24, 2019 | NCT04210258 | Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face | Merz Pharmaceuticals GmbH | Observational | Completed | Correction of Facial Wrinkles/Folds, Facial Volume Enhancement | 154 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04210258) |
| June 20, 2019 | NCT03992404 | Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by... | Merz Pharmaceuticals GmbH | Phase 3 | Active not recruiting | Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury | 603 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03992404) |
| June 14, 2019 | NCT03986424 | Local Study of Akatinol Memantine in VaD in Russia | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Vascular Dementia | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03986424) |
| August 22, 2017 | NCT03256942 | Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation | Merz Pharmaceuticals GmbH | Not applicable | Completed | Subjects Desiring Lip Augmentation | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03256942) |
| October 21, 2014 | NCT02270736 | Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling... | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Chronic Troublesome Sialorrhea, Cerebral Palsy, Stroke, Traumatic Brain Injury, Intellectual Disability | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02270736) |
| August 4, 2014 | NCT02207946 | Botulinum Toxin A to Treat Arm Tremor | Merz Pharmaceuticals GmbH | Phase 2 | Completed | Essential Tremor of the Upper Limbs | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02207946) |
| July 11, 2014 | NCT02188277 | Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy | Merz Pharmaceuticals GmbH | Phase 2 | Completed | Cerebral Palsy, Spastic Paraplegia and Hemiparesis, Equine and Equinovarus Foot Deformation | 64 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02188277) |
| March 19, 2014 | NCT02091739 | Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome... | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Chronic Troublesome Sialorrhea, Parkinson's Disease, Post-stroke, Traumatic Brain Injury | 184 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02091739) |
| December 6, 2013 | NCT02002884 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral... | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Cerebral Palsy, Spasticity | 351 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02002884) |
| July 30, 2013 | NCT01910896 | Effectiveness and Safety Study of Overnight Intensive Patch in Scars | Merz Pharmaceuticals GmbH | Not applicable | Completed | Post Dermatological Surgery Scars | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01910896) |
| July 23, 2013 | NCT01905683 | Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy | 370 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01905683) |
| July 16, 2013 | NCT01900041 | A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With... | Merz Pharmaceuticals GmbH | Phase 2 | Completed | Female Pattern Hair Loss, Androgenetic Alopecia (AGA), Ludwig Type 1, Ludwig Type 2 | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01900041) |
| July 11, 2013 | NCT01896895 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the Eyelid | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Bilateral Blepharospasm (BEB) | 61 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01896895) |
| July 9, 2013 | NCT01893411 | Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Lower Limb Spasticity Due to Cerebral Palsy | 311 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01893411) |
| October 26, 2012 | NCT01714960 | Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients | Merz Pharmaceuticals GmbH | Phase 1 | Completed | Healthy Volunteers and Glaucoma Patients | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01714960) |
| September 17, 2012 | NCT01686061 | Blepharospasm Patient Survey for Patients With Blepharospasm | Merz Pharmaceuticals GmbH | Observational | Completed | Blepharospasm | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01686061) |
| May 22, 2012 | NCT01603459 | Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Spasticity of the Upper and Lower Limb Due to Cerebral Causes | 155 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01603459) |
| January 24, 2012 | NCT01515371 | Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring | Merz Pharmaceuticals GmbH | Phase 2 | Terminated | Habitual Snoring | 8 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01515371) |
| December 6, 2011 | NCT01486264 | Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex | Merz Pharmaceuticals GmbH | Phase 4 | Completed | Cervical Dystonia | 283 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01486264) |
| November 3, 2011 | NCT01464307 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Post-stroke Spasticity of the Lower Limb | 290 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01464307) |
| July 12, 2011 | NCT01392300 | Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke | Merz Pharmaceuticals GmbH | Phase 3 | Completed | Post-stroke Spasticity of the Upper Limb | 317 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01392300) |
| February 28, 2011 | NCT01305187 | Non-inferiority of Belotero® Basic Versus Juvéderm® Ultra 3 | Merz Pharmaceuticals GmbH | Phase 4 | Completed | Physiological Stress, Disorder of Aging, Skin Diseases, Wrinkles, Nasolabial Folds | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01305187) |
| December 16, 2010 | NCT01261741 | Investigation of Memantine in the Treatment of Memory, Concentration or Attention Problems | Merz Pharmaceuticals GmbH | Phase 2 | Completed | Memory Disorder, Retention Disorder, Cognitive, Subjective Cognitive Impairment, Memory, Concentration or Attention... | 299 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01261741) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 11 |
| Phase 2 | 12 |
| Phase 3 | 28 |
| Phase 4 | 6 |
| Not applicable | 2 |
| Observational | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 54 |
| Terminated | 5 |
| Active not recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Tinnitus | 5 |
| Torticollis | 3 |
| Alzheimer Disease | 3 |
| Cerebral Palsy | 3 |
| Brain Injuries, Traumatic | 3 |
| Blepharospasm | 3 |
| Nystagmus, Pathologic | 2 |
| Cicatrix | 1 |
| Stroke | 1 |
| Intellectual Disability | 1 |
| Muscle Spasticity | 1 |
| Parkinson Disease | 1 |
| Dementia, Vascular | 1 |
| Skin Diseases | 1 |
| Memory Disorders | 1 |
| Alopecia | 1 |
| Sleep Apnea Syndromes | 1 |
| Snoring | 1 |
| Paraplegia | 1 |
| Paresis | 1 |
| Nystagmus, Congenital | 1 |
| Multiple Sclerosis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Mechanical engineering firms in the United States](https://specstream.ai/data/businesses/mechanical-engineering-firms/united-states)
- [Farming services in the United States](https://specstream.ai/data/businesses/farming-services/united-states)
- [Book magazine distribution companies in the United States](https://specstream.ai/data/businesses/book-magazine-distribution-companies/united-states)
- [Trailer rental companies in the United States](https://specstream.ai/data/businesses/trailer-rental-companies/united-states)
- [Pediatric gastroenterology practices in the United States](https://specstream.ai/data/businesses/pediatric-gastroenterology-practices/united-states)
